In an 87-year-old woman with type 2 diabetes, stage 2 chronic kidney disease, hypertension, suspected rheumatoid arthritis, osteoporosis, osteoarthritis, small vessel cerebrovascular disease, and a history of a secondary generalized focal seizure requiring hospitalization, currently treated with Toujeo, aspirin, omeprazole, prednisone 2.5, denosumab, fentanyl patch 12.5, trazodone, levetiracetam, and metamizole, who presents with insomnia, nocturnal agitation (verbal outbursts, continuous complaints), and is very apathetic and barely eats during the day, her family doctor wants to prescribe an antipsychotic but does not have authorization to prescribe a second-generation antipsychotic. While waiting for the geriatrics consultation, is it better to prescribe haloperidol or a benzodiazepine like lormetazepam?
Fuente:
Zenodo
Enregistré dans:
| Auteur principal: | |
|---|---|
| Format: | Recurso digital |
| Publié: |
Zenodo
2026
|
| Sujets: | |
| Accès en ligne: | |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
| _version_ | 1866901160040857600 |
|---|---|
| author | Tripdatabase |
| author_facet | Tripdatabase |
| contents | Prescribing haloperidol or lormetazepam in this elderly patient involves significant safety concerns, necessitating cautious decision-making. Non-pharmacological approaches should be prioritized where possible. |
| format | Recurso digital |
| id | zenodo_https___doi_org_10_5281_zenodo_18904519 |
| institution | Zenodo |
| language | |
| publishDate | 2026 |
| publisher | Zenodo |
| record_format | zenodo |
| spellingShingle | In an 87-year-old woman with type 2 diabetes, stage 2 chronic kidney disease, hypertension, suspected rheumatoid arthritis, osteoporosis, osteoarthritis, small vessel cerebrovascular disease, and a history of a secondary generalized focal seizure requiring hospitalization, currently treated with Toujeo, aspirin, omeprazole, prednisone 2.5, denosumab, fentanyl patch 12.5, trazodone, levetiracetam, and metamizole, who presents with insomnia, nocturnal agitation (verbal outbursts, continuous complaints), and is very apathetic and barely eats during the day, her family doctor wants to prescribe an antipsychotic but does not have authorization to prescribe a second-generation antipsychotic. While waiting for the geriatrics consultation, is it better to prescribe haloperidol or a benzodiazepine like lormetazepam? Tripdatabase elderly patient insomnia agitation antipsychotic haloperidol benzodiazepine lormetazepam geriatrics mental health initial management Prescribing haloperidol or lormetazepam in this elderly patient involves significant safety concerns, necessitating cautious decision-making. Non-pharmacological approaches should be prioritized where possible. |
| title | In an 87-year-old woman with type 2 diabetes, stage 2 chronic kidney disease, hypertension, suspected rheumatoid arthritis, osteoporosis, osteoarthritis, small vessel cerebrovascular disease, and a history of a secondary generalized focal seizure requiring hospitalization, currently treated with Toujeo, aspirin, omeprazole, prednisone 2.5, denosumab, fentanyl patch 12.5, trazodone, levetiracetam, and metamizole, who presents with insomnia, nocturnal agitation (verbal outbursts, continuous complaints), and is very apathetic and barely eats during the day, her family doctor wants to prescribe an antipsychotic but does not have authorization to prescribe a second-generation antipsychotic. While waiting for the geriatrics consultation, is it better to prescribe haloperidol or a benzodiazepine like lormetazepam? |
| topic | elderly patient insomnia agitation antipsychotic haloperidol benzodiazepine lormetazepam geriatrics mental health initial management |
| url | https://doi.org/10.5281/zenodo.18904519 |